Doximity Inc (DOCS, Financial) is set to release its Q3 2025 earnings on Feb 6, 2025. The consensus estimate for Q3 2025 revenue is $152.82 million, and the earnings are expected to come in at $0.27 per share. The full year 2025's revenue is expected to be $0.54 billion, and the earnings are expected to be $0.85 per share. More detailed estimate data can be found on the Forecast page.
Doximity Inc (DOCS, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Doximity Inc (DOCS) have increased from $0.52 billion to $0.54 billion for the full year 2025 and from $0.57 billion to $0.60 billion for 2026. Similarly, earnings estimates have increased from $0.79 per share to $0.85 per share for the full year 2025 and from $0.88 per share to $0.98 per share for 2026.
Doximity Inc (DOCS, Financial) Reported History
In the previous quarter of 2024-09-30, Doximity Inc's (DOCS) actual revenue was $136.83 million, which beat analysts' revenue expectations of $127.15 million by 7.61%. Doximity Inc's (DOCS) actual earnings were $0.22 per share, which beat analysts' earnings expectations of $0.20 per share by 11.11%. After releasing the results, Doximity Inc (DOCS) was up by 34.15% in one day.
Doximity Inc (DOCS, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 18 analysts, the average target price for Doximity Inc (DOCS) is $55.56, with a high estimate of $65 and a low estimate of $31. The average target implies a downside of -5.44% from the current price of $58.75.
Based on GuruFocus estimates, the estimated GF Value for Doximity Inc (DOCS, Financial) in one year is $50.96, suggesting a downside of -13.26% from the current price of $58.75.
Based on the consensus recommendation from 20 brokerage firms, Doximity Inc's (DOCS, Financial) average brokerage recommendation is currently 2.6, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
